Avian antibodies (IgY) targeting spike glycoprotein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) inhibit receptor binding and viral replication.
<h4>Background</h4>The global pandemic of Coronavirus infectious disease 2019 (COVID-19), caused by SARS-CoV-2, has plunged the world into both social and economic disarray, with vaccines still emerging and a continued paucity of personal protective equipment; the pandemic has also highl...
Saved in:
| Main Authors: | Chad Artman, Kyle D Brumfield, Sahil Khanna, Julius Goepp |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2021-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0252399&type=printable |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Evaluating the Protective Role of Intranasally Administered Avian-Derived IgY Against SARS-CoV-2 in Syrian Hamster Models
by: Mónika Madai, et al.
Published: (2024-12-01) -
IgY-mediated protection against Vibrio cholerae infection: Efficacy of avian antibodies targeting a chimeric recombinant protein
by: Hasna Sadat Naghash Hoseini, et al.
Published: (2024-06-01) -
In silico-based Discovery of New Potential Drugs Targeting Severe Acute Respiratory Syndrome Coronavirus 2 Spike Glycoprotein
by: Hayam Abdelkader, et al.
Published: (2021-10-01) -
Eliciting Antigen-Specific Egg-Yolk IgY with Naked DNA
by: Marco Romito, et al.
Published: (2001-09-01) -
Using IgY for diagnosis of respiratory infections: practical application in COVID-19
by: Cícero Matheus Lima Amaral, et al.
Published: (2025-12-01)